References

• Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013; 93(1):137-188. google scholar
• Maiese K. New insights for oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2015;87596. google scholar
• Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2020;8609213. google scholar
• Huang X, Sun M, Li D, et al. Augmented NADPH oxidase activity and p22phox expression in monocytes underlie oxidative stress of patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;91(3):371-380. google scholar
• Ghoshal K, Das S, Aich K, Goswami S, Chowdhury S, Bhat-tacharyya M. A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia. Clin Chim Acta. 2016;458:144-153. google scholar
• Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med. 2007;43(3):332-347. google scholar
• Garaa AG, Rodriguez MR, Alonso CG, Ochoa DYR, Aguilar CA. Myeloperoxidase is associated with insulin resistance and inflammation in overweight subjects with first-degree relatives with type 2 diabetes mellitus. Diabetes Metab J. 2015;39(1):59-65. google scholar
• Khan AA, Alsahli MA, Rahmani AH. Myeloperoxidase as an active disease biomarker: Recent biochemical and pathological perspectives. Med Sci (Basel). 2018;6(2):33. google scholar
• Ndrepepa G. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease. Clin Chim Acta. 2019;493:36-51. google scholar
• Davies MJ. Protein oxidation and peroxidation. Biochem J. 2016;473(7):805-825. google scholar
• Saha P, Banerjee P, Auddya L, et al. Simple modified colorimetric methods for assay of total oxidative stress and antioxidant defense in plasma: Study in diabetic patients. Arch Med. 2015; 7(5):1-7. google scholar
• Boyacı I, Yiğitbaşı T, Ankaralı H. Is oxidative stress a conse-quence of hyperglycemia? Or is hyperglycemia the consequence of oxidative stress? Or are both caused by insulin resistance? Int Arch Endocrinol Clin Res. 2021;7(1):023. google scholar
• Sitar ME, Aydin S, Çakatay U. Human serum albumin and its relation with oxidative stress. Clin Lab. 2013;59(9-10):945-952. google scholar
• Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 1994;233:380-385. google scholar
• Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329(1-2):23-38. google scholar
• Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Ad-vanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304-1313. google scholar
• Höhn A, Jung T, Grune T. Pathophysiological importance of ag-gregated damaged proteins. Free Radic Biol Med. 2014;71:70-89. google scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):15-33. google scholar
• Reusch VM Jr, Burger MM. Distribution of marker enzymes between mesosomal and protoplast membranes. J Biol Chem. 1974;249(16):5337-5345. google scholar
• Ferdausi N, Anik MEK, Binti NN, Islam LN. Oxidase enzyme ac-tivities and their correlations with antioxidative stress biomarkers in patients with acute coronary syndrome in Bangladesh. World J Cardiovasc Dis. 2020;10(4): 163-177. google scholar
• Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measure-ment of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206-209. google scholar
• Choudhury TZ, Kamruzzaman M, Islam LN. Investigation of the cellular and soluble markers of inflammation for the assessment of cardiovascular risk in patients with acute coronary syndrome in Bangladesh. Int J Electron Healthc. 2019;11(1): 67-80. google scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239(1):70-76. google scholar
• Haque R, Hafiz FB, Habib MA, Radeen KR, Islam LN. Role of complete blood count, antioxidants, and total antioxidant capacity in the pathophysiology of acute coronary syndrome. Afr J Bio Sci. 2022;4(1):37-47. google scholar
• Rodkey FL. Direct spectrophotometric determination of albumin in human serum. Clin Chem. 1965;11(4):478-487. google scholar
• Binti NN, Ferdausi N, Anik MEK, Islam LN. Associa-tion of albumin, fibrinogen, and modified proteins with acute coronary syndrome. PLOS One. 2022;17(7):e0271882. doi:10.1371/journal.pone.0271882 google scholar
• Levine RL, Garland D, Oliver CN, et al. Determination of car-bonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464-478. google scholar
• Geetha A, Gopalakrishnan S, Umadevi R. Study on the impact of family history of diabetes among type 2 diabetes mellitus patients in an urban area of Kancheepuram district, Tamil Nadu. Int J Community Med Public Health. 2017;4(11):4151-4156. google scholar
• Savu O, Serafinceanu C, Grajdeanu IV, Iosif L, Gaman L, Stoian I. Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus. J Int Med Res. 2014;42(2):523-529. google scholar
• Marra G, Cotroneo P, Pitocco D, et al. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncom-plicated type 1 diabetes: a case for gender difference. Diabetes Care. 2002;25(2):370-375. google scholar
• Fatima N, Faisal SM, Zubair S, et al. Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type 1 diabetes: Correlation with age and glycemic condition in diabetic human subjects. PLOS One. 2016;11(8):e0161548. doi:10.1371/journal.pone.0161548 google scholar
• Siddique MAH, Tamannaa Z, Kamaluddin SM, et al. Total an-tioxidant status in newly-diagnosed type II diabetes patients in Bangladeshi population. JMol Pathophysiol. 2014;5(1):5-9. google scholar
• Al-Deen ZMM, Ajeena IA. Study of total antioxidant capacity in patients with diabetic peripheral neuropathy. Med J Babylon. 2015;12(1):192-201. google scholar
• Rehman A, Zamir S, Bhatti A, Jan SS, Ali S, Wazir F. Evalua-tion of albuminuria, total plasma proteins, and serum albumin in diabetics. Gomal J Med Sci. 2012;10(2):198-200. google scholar
• Cheng PC, Hsu SR, Cheng YC. Association between serum al-bumin concentration and ketosis risk in hospitalized individuals with type 2 diabetes mellitus. J Diabetes Res. 2016;1269706. google scholar
• Bansal S, Chawla D, Siddarth M, Banerjee BD, Madhu SV, Tri-pathi AK. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activ-ity in type 2 diabetic patients with vascular complications. Clin Biochem. 2013;46(1-2):109-114. google scholar
• Kalousova M, Fialova L, Skrha J, et al. Oxidative stress, inflam-mation and autoimmune reaction in type 1 and type 2 diabetes mellitus. PragueMedRep. 2004;105(1):21-28. google scholar
• Ates I, Kaplan M, Yuksel M, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine. 2016;51(1):47-51. google scholar
• Michelis R, Kristal B, Snitkovsky T, Sela S. Oxidative mod-ifications impair albumin quantification. Biochem Biophys Res Commun. 2010;401(1):137-142. google scholar
• Witko-Sarsat V, Gausson V, Nguyen AT, et al. AOPP-induced acti-vation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int. 2003;64(1):82-91. google scholar
• Yuan F, Liu SX, Tian JW. Advanced oxidation protein products induce reactive oxygen species production in endothelial cells. Di Yi Jun Yi Da Xue Xue Bao. 2004;24(12):1350-1352. google scholar

Citations